Living Cell Technologies (ASX: LCT), a Melbourne-based biotechnology company, has made substantial advancements in its quest to establish a robust and diversified product candidate pipeline. The...
Tag: hb-featured
Incannex Healthcare Advances with FDA Application
Incannex Healthcare (ASX: IHL), an emerging player in the healthcare industry, is making significant strides through its subsidiary, Psychennex Pty Ltd. The company has embarked on...
Recce Pharmaceuticals Announces New Share Offerings
The Rise of Recce Pharmaceuticals In the ever-evolving world of pharmaceuticals, companies are constantly seeking innovative solutions to address global health challenges. One such company making...
Arovella Therapeutics Explores Enhanced iNKT Cell Therapy
Arovella Therapeutics Ltd (ASX: ALA) is forging ahead with discussions and collaboration with the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center, leveraging their invariant...
Incannex Makes Key Appointments for Sleep Apnoea Trial
Incannex Healthcare (ASX: IHL), a clinical-stage pharmaceutical company, has taken a significant step towards enhancing the comfort of sleep apnoea sufferers and disrupting the multi-billion dollar...
Chimeric Therapeutics Receives Patent in Japan
Leading the charge in clinical-stage cell therapy, Chimeric Therapeutics (ASX: CHM) has achieved a significant milestone by securing a patent in Japan. The patent underscores Chimeric’s...
Neurotech International Initiates Clinical Trial for Rett Syndrome
Neurotech International (ASX: NTI), a clinical-stage biopharmaceutical development company, has achieved a significant milestone by initiating the dosing of the first patient in its ground breaking...
LCT Embraces AI-Powered Drug Discovery and Development
Living Cell Technologies (ASX: LCT), a prominent biotechnology firm, is gearing up for a major transformation, seeking approval from its shareholders to rebrand as Algorae Pharmaceuticals....